vinpocetine has been researched along with Nerve Degeneration in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cselényi, Z; Gulyás, B; Halldin, C; Hillert, J; Karrenbauer, VD; Kostulas, K; Savic, I; Shchukin, Y; Takano, A; Vas, A | 1 |
| Csillik, B; Farkas, I; Knyihár-Csillik, E; Krisztin-Péva, B; Mihály, A | 1 |
1 trial(s) available for vinpocetine and Nerve Degeneration
| Article | Year |
|---|---|
Functional neuroimaging in multiple sclerosis with radiolabelled glia markers: preliminary comparative PET studies with [11C]vinpocetine and [11C]PK11195 in patients.
Topics: Adult; Anticonvulsants; Antineoplastic Agents; Binding, Competitive; Biomarkers; Brain Mapping; Carbon Radioisotopes; Cerebral Cortex; Female; Gliosis; Humans; Isoquinolines; Ligands; Male; Molecular Structure; Multiple Sclerosis; Nerve Degeneration; Neurodegenerative Diseases; Neuroglia; Positron-Emission Tomography; Predictive Value of Tests; Radioligand Assay; Receptors, GABA-A; Vinca Alkaloids | 2008 |
1 other study(ies) available for vinpocetine and Nerve Degeneration
| Article | Year |
|---|---|
Mitigation of nociception via transganglionic degenerative atrophy: possible mechanism of vinpocetine-induced blockade of retrograde axoplasmic transport.
Topics: Analgesics; Animals; Axonal Transport; Disease Models, Animal; Male; Nerve Degeneration; Pain; Pain Measurement; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Spinal Cord; Vinca Alkaloids | 2008 |